BIOA
BioAge Labs, Inc
6.60$
-2.9%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | +592.8% | -8.5% | +105.2% | +6.2% | -4.0% | -6.3% | -5.3% | -3.3% | +34.8% | -0.2% | |
| – | – | +606.6% | -8.5% | +105.6% | +6.1% | -9.0% | -7.1% | -3.6% | -1.4% | +36.6% | -15.7% | |
| – | – | +703.9% | -8.6% | +110.2% | +5.9% | -27.3% | -14.4% | -2.2% | -12.4% | +28.0% | -69.4% | |
| – | – | +703.9% | -8.6% | +110.2% | +5.9% | -9.5% | -7.2% | -3.9% | -1.6% | +36.3% | -16.8% | |
| – | – | – | – | – | – | – | +67.0% | -14.6% | +49.3% | -7.8% | -11.8% | |
| – | – | +83.2% | -1.0% | -93.5% | +48.6% | -12.6% | -10.8% | +0.9% | -17.3% | -18.9% | +18.8% | |
| – | – | -74.0% | -14.3% | +47.0% | +45.6% | -14.5% | -3.8% | +7.3% | -17.8% | -21.4% | +21.4% | |
| – | – | -86.0% | +0.0% | -0.4% | -1.1% | +8.0% | -7.1% | -24.4% | -31.4% | -44.1% | -60.4% | |
| – | – | +24.2% | -36.8% | +43.2% | -4.9% | +99.8% | -66.7% | +277.6% | -46.7% | +14.7% | +84.4% | |
| – | – | -17.2% | -20.9% | -26.6% | -36.5% | -57.8% | – | – | – | – | – | |
| – | – | – | – | – | +3.0% | -3.1% | -5.9% | -5.9% | -2.0% | +39.4% | -1.1% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | -0.1% | +0.1% | +4.8% | +0.0% | +0.0% | +0.0% | +0.7% | +17.6% | +5.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.